Seattle Genetics (SGEN) Tops Q3 EPS by 6c

October 27, 2016 4:13 PM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Seattle Genetics (NASDAQ: SGEN) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $106.3 million versus the consensus estimate of $101.74 million.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment